USFDA issues warning letter to Lupin’s Goa, Indore plants Industry-The Economic Times — November 16, 2017 comments off On Lupin’s Pithampur (Indore) plant, the US health regulator said the company invalidated initial OOS laboratory results without adequate investigations.
